Current Pharmaceutical Design of Antituberculosis Drugs: Future Perspectives

E-ISSN： 1873-4286|16|24|2656-2665

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.24, 2010-08, pp. : 2656-2665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Kinetoplastid Chemotherapy Revisited: Current Drugs, Recent Advances and Future Perspectives

Current Medicinal Chemistry, Vol. 17, Iss. 33, 2010-01 ,pp. : 4027-4051

Bentham Science Publishers

Access to resources Recommend Favorite

Old Drugs-Current Perspectives

Current Pharmacogenomics, Vol. 2, Iss. 2, 2004-06 ,pp. : 163-173

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Prodrugs: Pharmaceutical Design and Current Perspectives (Executive Guest Editor: Josef Jampilek)]

Current Pharmaceutical Design, Vol. 17, Iss. 32, 2011-11 ,pp. : 3480-3481

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 175-187

Bentham Science Publishers

Access to resources Recommend Favorite

Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design

Current Drug Targets, Vol. 18, Iss. 16, 2017-11 ,pp. : 1904-1918

Bentham Science Publishers

Access to resources Recommend Favorite